Testing effectiveness (Phase 2)Study completedNCT04388176What this trial is testingCold Challenge With C21 in RPWho this might be right forRaynaud PhenomenonSystemic Sclerosis Vicore Pharma AB 20
Testing effectiveness (Phase 2)Study completedNCT00480753What this trial is testingDose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's PhenomenonWho this might be right forRaynaud's Disease MediQuest Therapeutics 15
Large-scale testing (Phase 3)Study completedNCT01280266What this trial is testingEfficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud PhenomenonWho this might be right forRaynaud Phenomenon Seoul National University Hospital 29
Post-approval studies (Phase 4)Study completedNCT00048776What this trial is testingSafety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Otsuka America Pharmaceutical 75
Not applicableStudy completedNCT02683408What this trial is testingDiosmiplex (Vasculera®) in Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Primus Pharmaceuticals 87
Very early researchStudy completedNCT02583789What this trial is testingAssess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Brigham and Women's Hospital 12
Post-approval studies (Phase 4)Not Yet RecruitingNCT07112183What this trial is testingOpen Label Treprostinil Raynaud's StudyWho this might be right forRaynaud's DiseaseRaynaud PhenomenaRaynauds Brigham and Women's Hospital 30
Large-scale testing (Phase 3)UnknownNCT00577304What this trial is testingA Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Other Autoimmune Disease MediQuest Therapeutics 200
Not applicableStudy completedNCT03211325What this trial is testingIdentification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.Who this might be right forRaynaud's Phenomenon Isolated PrimaryRaynaud's Phenomenon (Secondary)Healthy University Hospital, Grenoble 29
Testing effectiveness (Phase 2)Ended earlyNCT01315899What this trial is testingEfficacy of ORM-12741 for Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Orion Corporation, Orion Pharma 15
Not applicableUnknownNCT01378845What this trial is testingPrognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on HandsWho this might be right forRaynaud's PhenomenonSkin Necrosis Christoph Hehrlein 30
Not applicableStudy completedNCT00822354What this trial is testingTadalafil for the Treatment of Raynaud'sWho this might be right forRaynaud Northwestern University 10
Testing effectiveness (Phase 2)Study completedNCT02260557What this trial is testingEffects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Actelion 74
Large-scale testing (Phase 3)Study completedNCT03717961What this trial is testingEfficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud Phenomenon Secondary to Systemic Sclerosis Assistance Publique - Hôpitaux de Paris 91
Testing effectiveness (Phase 2)Study completedNCT02228850What this trial is testingStudy of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Not applicableStudy completedNCT01072669What this trial is testingEfficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or FeetWho this might be right forIschemia Soumya Chatterjee 20
Post-approval studies (Phase 4)Study completedNCT00048763What this trial is testingSafety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Otsuka America Pharmaceutical 75
Large-scale testing (Phase 3)Study completedNCT00266669What this trial is testingPhase III Study of Topical Gel for Treatment and Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's Disease MediQuest Therapeutics 200
Large-scale testing (Phase 3)Study completedNCT00253331What this trial is testingLab Study of MQX-503 in Treatment of Raynaud'sWho this might be right forRaynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune Disease MediQuest Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT03867097What this trial is testingIntravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)Who this might be right forRaynaud Phenomenon Secondary to Systemic Sclerosis Civi Biopharma, Inc. 34